المؤلفون: Lee D. Cranmer, Sigrun Hallmeyer, Rene Gonzalez, Anna C. Pavlick, John D. Hainsworth, F. Stephen Hodi, Lynn M. Schuchter, Bann Mo Day, C. Lance Cowey, David F. McDermott, David H. Lawson, R. Linke, Fred J. Kudrik, Brendan D. Curti, Paul B. Chapman, Kim Margolin, Keith T. Flaherty, Omid Hamid, Gerald P. Linette, Antoni Ribas, Lawrence E. Flaherty

المصدر: Cancer journal (Sudbury, Mass.), vol 20, iss 1

مصطلحات موضوعية: Oncology, Male, Cancer Research, Skin Neoplasms, Indoles, medicine.medical_treatment, neoplasm metastasis/drug therapy, Melanoma/drug therapy, Neoplasm Metastasis, Vemurafenib, Melanoma, Cancer, education.field_of_study, Sulfonamides, clinical trial, Middle Aged, brain neoplasms/drug therapy, melanoma/genetics, Female, Patient Safety, medicine.drug, medicine.medical_specialty, Population, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Ipilimumab, QT interval, Clinical Research, Internal medicine, medicine, BRAF protein, Humans, human, Oncology & Carcinogenesis, education, Adverse effect, brain neoplasms/secondary, business.industry, Neurosciences, vemurafenib/adverse effects, medicine.disease, vemurafenib/therapeutic use, Dermatology, United States, Clinical trial, Radiation therapy, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3953e48760c3f30385fbbce2f234de
https://escholarship.org/uc/item/6jv605j1